San Francisco, CA, January 14, 2020 – Strategikon Pharma, developer of the novel clinical trial planning, budgeting, outsourcing and vendor management platform Clinical Maestro™, announced that Founder and CEO Anca Copaescu has been recognized by Silicon Review as one of the Best 30 CEOs in 2020 for her outstanding leadership and commitment to the field.
“I am honored to be included as part of this tremendous group of highly accomplished leaders,” said Copaescu. “Our mission is to develop modern tools that profoundly impact the way pharmaceutical clinical trials are planned, budgeted, and outsourced through speed, efficiency, and cost reductions. I hope to continue shaping Strategikon into a successful company and see Clinical Maestro become the platform of choice for clinical outsourcing, budgeting and vendor oversight.” Anca’s full interview with Silicon Review can be read here…
Anca Maria Copaescu is the dynamo that powers Strategikon Pharma. She envisioned and created Clinical Maestro™ by drawing on more than 15 years’ of professional experience as a business visionary and strategic leader in the clinical research industry with both pharmaceutical companies and service providers. Anca’s frustration with the existing solutions for clinical study planning, outsourcing and financial management drove her to build her own comprehensive platform – Clinical Maestro™- to harmonize clinical study outsourcing processes from planning, through execution, to the end of the clinical contract and study.
Mark Weinstein, Board Member and former President and CEO of Bioclinica stated: “I was introduced to Anca as Strategikon Pharma was being formed and I was immediately impressed with her market knowledge and endless energy. Over the past several years, I have watched Anca build and manage a team that has produced a world class product while being extremely capital efficient. Anca has the combination of skills and traits to be an effective CEO; and I look forward to watching Strategikon Pharma succeed under her guidance and leadership.”
“Within the first month I worked with Anca, I recall thinking ‘this woman will run her own company someday’. Now I have worked with Anca for more than a dozen years at two different companies, and today as a co-founder at Strategikon Pharma. This is an incredible achievement for Anca. She is one of the hardest working, smartest and most entrepreneurial people I have ever worked with at any level,” commented Mark Di Ianni, Co-founder and Board Chairman, Strategikon Pharma.
About Clinical Maestro™ by Strategikon Pharma
Clinical Maestro™ is a cloud-based platform that more efficiently budgets, sources and manages complex clinical programs. It enables all participants in clinical trials, Sponsor Companies and Service Providers, to plan studies, model and manage clinical contracts in an entirely novel way. Faster. More accurately. With less effort. For more information, please visit www.clinicalmaestro.com.
Contact:
Farah Ahmad
Strategikon Pharma
514-978-1112
